Previous 10 | Next 10 |
On my previous article on T2 Biosystems ( TTOO ), I said my next article would be about putting some numbers together and coming up with a possible price target, based on the information I wrote in that article. However, since then, we have a lot of new developments, so I thought commenting ...
White Diamond’s new findings show why AXDX’s Pheno system is unlikely to realize the revenue the street is expecting. The issues we have found have been missed by most. Accelerate Diagnostics ( AXDX ) is a rapid diagnostic company that relies on one product, the Pheno syst...
Gainers: Sintx Technologies (NASDAQ: SINT ) +71% . Ruhnn Holding Limited (NASDAQ: RUHN ) +29% . Jaguar Health (NASDAQ: JAGX ) +19% . T2 Biosystems (NASDAQ: TTOO ) +15% . OncoCyte Corporation (NYSEMKT: OCX ) +13% . Libbey (NYSEMKT: LBY ) +13% . Cyclerion Therapeutics (NASDAQ: CY...
Gainers: Yuma Energy (NYSEMKT: YUMA ) +145% . T2 Biosystems (NASDAQ: TTOO ) +57% . Lexicon Pharmaceuticals (NASDAQ: LXRX ) +29% . Bicycle Therapeutics (NASDAQ: BCYC ) +25% . CARBO Ceramics (NYSE: CRR ) +23% . Luby's (NYSE: LUB ) +23% . CBL & Associates Properties (NYSE: CBL...
LEXINGTON, Mass., Sept. 11, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it has been awarded a milestone-based con...
Yuma Energy (NYSEMKT: YUMA ) +69% announces third party purchase of senior secured bank debt. More news on: Yuma Energy, Inc., T2 Biosystems, Inc., Lexicon Pharmaceuticals, Inc., Stocks on the move, Read more ...
The U.S. Department of Health and Human Service's Biomedical Advanced Research and Development Authority (BARDA) has awarded a contract to T2 Biosystems (NASDAQ: TTOO ) to support the development of diagnostics for sepsis-causing pathogens and antibiotic-resistance genes. More news on: T...
Contract includes initial phase valued at $6 million, with a total value up to $69 million Call will also cover restructuring of CRG term loan agreement and Breakthrough Technology contract with Premier Inc. Company to host conference call and webcast at 8:30 a.m. ET on Wednesday, ...
LEXINGTON, Mass., Sept. 10, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it has restructured its Term Loan Agreement with CRG Servicing LLC (“CRG&...
LEXINGTON, Mass., Sept. 10, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that Premier Inc., a healthcare improvement company, as part of their Technology...
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced financial and operational results for the second quarter ended Jun...
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a territory exclusive distribution agreement in Malaysia and Indonesia. Under the ter...
LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the second quarter 2024 and business updates after mar...